NC
COLL icon

NBW Capital’s Collegium Pharmaceutical COLL Stock Holding History

NBW Capital’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-56,112
Closed -$1.33M – 86
2021
Q2 		$1.33M Buy
56,112
+2,225
+4% +$51.4K 0.32% 74
2021
Q1 		$1.28M Buy
53,887
+3,504
+7% +$83.2K 0.35% 70
2020
Q4 		$1.01M Sell
50,383
-3,184
-6% -$62.2K 0.31% 70
2020
Q3 		$1.11M Buy
53,567
+12,067
+29% +$218K 0.37% 68
2020
Q2 		$726K Buy
41,500
+11,443
+38% +$224K 0.26% 67
2020
Q1 		$491K Sell
30,057
-1,532
-5% -$31.6K 0.23% 65
2019
Q4 		$650K Sell
31,589
-1,214
-4% -$20.2K 0.18% 71
2019
Q3 		$377K Sell
32,803
-2,665
-8% -$30.4K 0.11% 71
2019
Q2 		$466K Sell
35,468
-706
-2% -$9.44K 0.13% 72
2019
Q1 		$548K Sell
36,174
-1,586
-4% -$25.4K 0.15% 70
2018
Q4 		$648K Sell
37,760
-377
-1% -$6.45K 0.23% 69
2018
Q3 		$562K Sell
38,137
-1,446
-4% -$25.6K 0.15% 73
2018
Q2 		$944K Buy
39,583
+424
+1% +$10.4K 0.27% 70
2018
Q1 		$1M Sell
39,159
-29,891
-43% -$712K 0.31% 68
2017
Q4 		$1.27M Sell
69,050
-1,128
-2% -$16.2K 0.34% 66
2017
Q3 		$736K Buy
70,178
+8,972
+15% +$98.9K 0.2% 68
2017
Q2 		$766K Sell
61,206
-824
-1% -$8.14K 0.21% 68
2017
Q1 		$624K Buy
62,030
+1,114
+2% +$16.6K 0.17% 64
2016
Q4 		$948K Sell
60,916
-843
-1% -$14K 0.27% 61
2016
Q3 		$1.19M Sell
61,759
-347
-0.6% -$4.12K 0.34% 63
2016
Q2 		$736K Sell
62,106
-1,824
-3% -$30.1K 0.23% 62
2016
Q1 		$1.16M Buy
63,930
+444
+0.7% +$8.07K 0.37% 62
2015
Q4 		$1.75M Sell
63,486
-3,531
-5% -$74.4K 0.54% 57
2015
Q3 		$1.48M Sell
67,017
-250
-0.4% -$4.52K 0.44% 69
2015
Q2 		$1.2M Buy
+67,267
New +$1.16M 0.28% 68

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

NBW Capital's COLL Position: Q3 2021 in Review

NBW Capital sold out of Collegium Pharmaceutical (COLL) in Q3 2021, closing a stake of 56,112 shares — an estimated $1.33M sold.

NBW Capital first reported a position in COLL in Q2 2015 and held it in 25 quarters. The position peaked at $1.75M in Q4 2015. 154 funds tracked by Wall St. Rank hold COLL as of Q3 2021.

  • NBW Capital reported no remaining Collegium Pharmaceutical position as of Q3 2021 after selling out during the quarter.
  • NBW Capital sold 56,112 Collegium Pharmaceutical shares in Q3 2021, an estimated $1.33M.
  • NBW Capital first reported a position in Collegium Pharmaceutical in Q2 2015 and held it in 25 quarters.
  • NBW Capital's Collegium Pharmaceutical position peaked at $1.75M in Q4 2015.
  • 154 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2021.

Based on NBW Capital's 13F filing for Q3 2021, filed 3 Nov 2021.